To hinder the recruitment of TAMs, agents such as CSF1R antibodies and C-X-C motif chemokine ligand 12 (CXCL12) inhibitors, have been developed; these agents significantly inhibit cancer metastasis (98, 106). Here, CXCL12 is linked to cancer.